ED administration of thienopyridines in non-ST-segment elevation myocardial infarction: results from the NCDR.

ABSTRACT:

Objective

American Heart Association/American College of Cardiology guidelines recommend that patients with definite unstable angina or non-ST-segment elevation myocardial infarction (NSTEMI) receive dual antiplatelet therapy on presentation to the hospital when undergoing early invasive management or "as soon as possible" after admission when being managed conservatively. The guidelines do not specify whether these medications should be administered in the emergency department (ED). Our aim was to determine whether ED administration of a thienopyridine was associated with clinical outcomes among patients with NSTEMI.

Methods

We examined thienopyridine use in 39454 patients with NSTEMI who received a thienopyridine within 24 hours of presentation in the National Cardiovascul

SUBMITTER: Diercks DB 

PROVIDER: S-EPMC4045403 | biostudies-literature | 2013 Jul

REPOSITORIES: biostudies-literature